Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin adjunct to Narrative Exposure Therapy for chronic PTSD
2012-003072-39Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Oxytocin + Narrative Exposure Therapy with Placebo + Narrative Exposure Therapy (2 arms). Primary endpoints: PTSD symptoms and Depressive symptoms. Started Jul 2012; status: active.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2012-003072-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003072-39.